LUTS, ED, QOL: Alphabet soup or real concerns to aging men?

被引:27
作者
O'Leary, MP
机构
[1] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Urol, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA
[3] Sanofi Synthelabo, New York, NY USA
[4] Pfizer, Speakers Bur, New York, NY USA
[5] Boehringer Ingelheim KG, Med Advisory Board, Ingelheim, Germany
关键词
D O I
10.1016/S0090-4295(00)00742-1
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The severity of symptoms and the degree to which they negatively impact on quality of life (QOL) are the major factors prompting patients with benign prostatic hyperplasia (BPH) to seek treatment. Several tools have been developed to assess symptom severity in patients with BPH, including the International Prostate Symptom Score (IPSS), the Danish Prostate Symptom Score (DAN-PSS), and the International Continence Society (ICS) questionnaire. Data from the Veterans Affairs Cooperative Study show that reductions in IPSS scores predict global ratings of improvement with treatment. Instruments have also been developed to measure the impact of urinary symptoms on QOL and have shown that as symptom severity increases, the impact on QOL also increases. Data from studies conducted in the United States, France, Scotland, and Japan reveal a similar pattern regarding the impact of symptom severity on QOL. Studies have also demonstrated that medical treatment with alpha -blockers, for example, is associated with a reduction in symptoms and a corresponding improvement in QOL. Patients with BPH frequently also have coexisting erectile dysfunction, which significantly affects QOL. Thus, in addition to assessment of symptoms and QOL in patients with BPH, sexual function should also be assessed in these patients. (C) 2000, Elsevier Science Inc.
引用
收藏
页码:7 / 11
页数:5
相关论文
共 18 条
[1]  
BARRY MJ, 1995, MED CARE, V33, pAS145
[2]   THE AMERICAN-UROLOGICAL-ASSOCIATION SYMPTOM INDEX FOR BENIGN PROSTATIC HYPERPLASIA [J].
BARRY, MJ ;
FOWLER, FJ ;
OLEARY, MP ;
BRUSKEWITZ, RC ;
HOLTGREWE, HL ;
MEBUST, WK ;
COCKETT, ATK ;
BLAIVAS, JG ;
WEIN, AJ .
JOURNAL OF UROLOGY, 1992, 148 (05) :1549-1557
[3]   BENIGN PROSTATIC HYPERPLASIA SPECIFIC HEALTH-STATUS MEASURES IN CLINICAL RESEARCH - HOW MUCH CHANGE IN THE AMERICAN-UROLOGICAL-ASSOCIATION SYMPTOM INDEX AND THE BENIGN PROSTATIC HYPERPLASIA IMPACT INDEX IS PERCEPTIBLE TO PATIENTS [J].
BARRY, MJ ;
WILLIFORD, WO ;
CHANG, YC ;
MACHI, M ;
JONES, KM ;
WALKERCORKERY, E ;
LEPOR, H .
JOURNAL OF UROLOGY, 1995, 154 (05) :1770-1774
[4]  
D'Alisera PM, 1998, J UROLOGY, V159, P103
[5]   Sustained-release alfuzosin, finasteride and the combination of both in the treatment of benign prostatic hyperplasia [J].
Debruyne, FMJ ;
Jardin, A ;
Colloi, D ;
Resel, L ;
Witjes, WPJ ;
Delauche-Cavallier, MC ;
McCarthy, C ;
Geffriaud-Ricouard, C .
EUROPEAN UROLOGY, 1998, 34 (03) :169-175
[6]   The ICS-'BPH' study: The psychometric validity and reliability of the ICSmale questionnaire [J].
Donovan, JL ;
Abrams, P ;
Peters, TJ ;
Kay, HE ;
Reynard, J ;
Chapple, C ;
DeLaRosette, JJMCH ;
Kondo, A .
BRITISH JOURNAL OF UROLOGY, 1996, 77 (04) :554-562
[7]   VALIDATION OF A NEW QUALITY-OF-LIFE QUESTIONNAIRE FOR BENIGN PROSTATIC HYPERPLASIA [J].
EPSTEIN, RS ;
DEVERKA, PA ;
CHUTE, CG ;
PANSER, L ;
OESTERLING, JE ;
LIEBER, MM ;
SCHWARTZ, S ;
PATRICK, D .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1992, 45 (12) :1431-1445
[8]   5-year outcome of surgical resection and watchful waiting for men with moderately symptomatic benign prostatic hyperplasia: A department of Veterans Affairs cooperative study [J].
Flanigan, RC ;
Reda, DJ ;
Wasson, JH ;
Anderson, RJ ;
Abdellatif, M ;
Bruskewitz, RC .
JOURNAL OF UROLOGY, 1998, 160 (01) :12-16
[9]   Health-related quality of life associated with lower urinary tract symptoms in four countries [J].
Girman, CJ ;
Jacobsen, SJ ;
Tsukamoto, T ;
Richard, F ;
Garraway, WM ;
Sagnier, PP ;
Guess, HA ;
Rhodes, T ;
Boyle, P ;
Lieber, MM .
UROLOGY, 1998, 51 (03) :428-436
[10]   The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia [J].
Lepor, H ;
Williford, WO ;
Barry, MJ ;
Brawer, MK ;
Dixon, CM ;
Gormley, G ;
Haakenson, C ;
Machi, M ;
Narayan, P ;
Padley, RJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (08) :533-539